By Marc Chandler: The market has been focused on the negotiations over the private sector involvement in reducing Greece’s debt burden. The optimism that a deal would be reached shortly was one of the factors that helped the euro gain around 4 cents against the dollar in recent days. Although progress was reported over the [...]
By Ganaxi Small Cap Movers: Reports are that Facebook is preparing to file its S-1 with the SEC as early as this coming Wednesday, setting the stage for what would be one of the biggest IPOs. The company is estimated to raise as much as $10 billion, which would value the social networking giant at [...]
By Eric Parnell: Have we finally reached the end of the line for stocks in the current cycle? After over three years of unprecedentedly aggressive monetary policy injections, is this as good as it gets for the stock market? The events of the past week raise concerns that we may be soon approaching the point [...]
By Miriam Metzinger: Stocks discussed on the in-depth session of Jim Cramer’s Mad Money TV Program, Friday January 27. Enbridge Energy Partners (EEP), Arm Holdings (ARMH), Amazon (AMZN), Whirlpool (WHR), Chipotle Mexican Grill (CMG), Tractor Supply (TSCO), Core Labs (CLB), Allergan (AGN), Cummins (CMI), Dow Chemical (DOW), American Axle (AXL), Clorox (CLX) other stocks mentioned: [...]
By Miriam Metzinger: Stocks discussed on the Lightning Round session of Jim Cramer’s Mad Money TV Program, Friday January 27. Bullish Calls: Heckmann Corporation (HEK): “It’s both an oil and a natural gas play…there is less natural gas drilling, because in the last 20 days, we’ve had an unprecedented collapse of natural gas…everyone is freaking [...]
By Mike Scully: Price, as they say, is determined on the margins. This is especially true for inelastic goods. If 100 Tickle Me Elmo dolls exist in Walmart on Christmas eve, and 100 people absolutely need to have them, you don’t have a problem. The price will be some reasonable markup on the cost of [...]
This week, Swiss pharmaceutical giant Roche launched a hostile bid for San Diego-based Illumina (ILMN: Charts, News, Offers), the market leader in gene sequencing technology, for $5.7 billion, or $44.50 per share. Roche has given Illumina ten days t… This article was written by InvestorGuide.com.
By Miriam Metzinger: Stocks discussed on the in-depth session of Jim Cramer’s Mad Money TV Program, Thursday January 26. CEO Rick Hamada, Avnet (AVT). Other stock mentioned: Apple (AAPL) Avnet (AVT) is like a supermarket of tech and is a great gauge of the industry, especially semiconductors. The company called the bottom in semis 6 [...]
By Miriam Metzinger: Stocks discussed on the Lightning Round session of Jim Cramer’s Mad Money TV Program, Thursday January 26. Bullish Calls: Nokia (NOK), Microsoft (MSFT): “Nokia had a good number. That means MSFT is doing well. The way to play Nokia numbers is with MSFT.” Joy Global (JOY): “I think Joy Global is going [...]
By James Peters: We are all painfully aware of the current low interest rate environment. We are seeing drastic intervention by The Federal Reserve in order to stimulate the economy. This intervention is causing wide divergence amongst classes of fixed income securities. The Fed may control short term interest rates, but it is investors who [...]